{
    "clinical_study": {
        "@rank": "16695", 
        "acronym": "LETSVN", 
        "arm_group": [
            {
                "arm_group_label": "Group L", 
                "arm_group_type": "Active Comparator", 
                "description": "Group L Lidocaine load dose 1.5 mg / kg over 5 minutes, followed by continuous infusion of 2 mg / kg / h, which is maintained until the end of surgical procedure"
            }, 
            {
                "arm_group_label": "Group P", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Saline solution administered under the same regimen"
            }
        ], 
        "brief_summary": {
            "textblock": "There some evidence regarding the effect of lidocaine for the prevention of nausea and\n      vomiting in adults. The investigators want to know whether with intravenous lidocaine a\n      adjunct for general anesthesia for children between 2 and 12 years who are undergoing\n      tonsillectomy, with or without adenoids has the same effect."
        }, 
        "brief_title": "Intravenous Lidocaine in the Prevention of Postoperative Vomiting in Elective Tonsil Surgery", 
        "condition": [
            "Postoperative Nausea and Vomiting", 
            "Pain After Surgery"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Nausea", 
                "Vomiting", 
                "Postoperative Nausea and Vomiting"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children between 2 and 12 years\n\n          -  ASA I or II\n\n          -  Programmed for elective tonsillectomy with or without adenoidectomy under\n             general anesthesia\n\n        Exclusion Criteria:\n\n          -  Obesity, defined as body mass index (BMI) \u2265 95th percentile for age and sex.\n\n          -  Use of antiemetic drugs during the 24 hours before surgery.\n\n          -  Gastroesophageal reflux.\n\n          -  History of allergy to any of the drugs used in the study.\n\n          -  Down Syndrome."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "12 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "92", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01986309", 
            "org_study_id": "PG 08-12"
        }, 
        "intervention": {
            "arm_group_label": "Group L", 
            "intervention_name": "Lidocaine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Lidocaine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Postoperative", 
            "Nausea", 
            "Vomiting", 
            "Pain", 
            "Surgery"
        ], 
        "lastchanged_date": "November 11, 2013", 
        "location": {
            "contact": {
                "email": "fernando.altermatt@gmail.com", 
                "last_name": "Fernando Altermatt, Assistant Professor", 
                "phone": "+56 2 23548173"
            }, 
            "facility": {
                "address": {
                    "city": "Santiago", 
                    "country": "Chile", 
                    "state": "Regi\u00f3n Metropolitana", 
                    "zip": "8330024"
                }, 
                "name": "Divisi\u00f3n de Anestesia - Facultad de Medicina Pontificia Universidad Cat\u00f3lica"
            }, 
            "investigator": {
                "last_name": "Fernando R Altermatt, Assistant Professor", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Chile"
        }, 
        "number_of_arms": "2", 
        "official_title": "Use of Intravenous Lidocaine in the Prevention of Postoperative Vomiting in Elective Tonsil Surgery, With or Without Adenoids", 
        "overall_contact": {
            "email": "fernando.altermatt@gmail.com", 
            "last_name": "Fernando R Altermatt, Assistant Professor", 
            "phone": "+56 2 2354 3270"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Chile: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Evaluating the effectiveness of intravenous lidocaine during anesthesia to decrease the numbers of events (vomiting) during the immediate   postoperative period up to 24 hours postoperatively, comparing to placebo", 
            "safety_issue": "Yes", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01986309"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "The prevention of the composite \"nausea / or vomiting\"", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Compare frequency of vomiting by baseline risk", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Time to first vomiting", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Time at which discharge criteria are met Postanesthesia care unit (PACU)", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Length of stay in PACU unit", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "PACU opioid consumption", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Postoperative pain using Children and Infants Postoperative Pain Scale , face or Visual analoge Scale, as appropriate", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Postoperative agitation using Pediatric Anesthesia Emergence Delirium Scale", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Time to first emetic drug administered", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Type and number of doses of antiemetic drug requiered during hospitalization", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Total length of stay", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Analysis of cost-effectiveness.", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }
        ], 
        "source": "Pontificia Universidad Catolica de Chile", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pontificia Universidad Catolica de Chile", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}